14-80497489-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_152446.5(CEP128):āc.3275A>Gā(p.Tyr1092Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000106 in 1,607,554 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_152446.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CEP128 | NM_152446.5 | c.3275A>G | p.Tyr1092Cys | missense_variant | 25/25 | ENST00000555265.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CEP128 | ENST00000555265.6 | c.3275A>G | p.Tyr1092Cys | missense_variant | 25/25 | 5 | NM_152446.5 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152208Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000801 AC: 2AN: 249534Hom.: 0 AF XY: 0.00000741 AC XY: 1AN XY: 134916
GnomAD4 exome AF: 0.00000412 AC: 6AN: 1455228Hom.: 0 Cov.: 28 AF XY: 0.00000414 AC XY: 3AN XY: 724238
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152326Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74490
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 29, 2021 | The c.3275A>G (p.Y1092C) alteration is located in exon 24 (coding exon 23) of the CEP128 gene. This alteration results from a A to G substitution at nucleotide position 3275, causing the tyrosine (Y) at amino acid position 1092 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at